Title : Glycogen synthase kinase-3β inhibitor ameliorates imbalance of connexin 43 in an acute kidney injury model.

Pub. Date : 2015

PMID : 28962480






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study was designed to evaluate whether glycogen synthase kinase-3beta (GSK-3beta) inhibitor, 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) induced the the expression of connexin 43 (Cx43) to protect against renal ischemia-reperfusion (I/R) injury (RI/RI) in rats. 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione gap junction protein, alpha 1 Rattus norvegicus
2 This study was designed to evaluate whether glycogen synthase kinase-3beta (GSK-3beta) inhibitor, 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) induced the the expression of connexin 43 (Cx43) to protect against renal ischemia-reperfusion (I/R) injury (RI/RI) in rats. 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione gap junction protein, alpha 1 Rattus norvegicus
3 The results indicated that TDZD-8 improved the recovery of renal function, reduced oxidative stress and inflammation injury, and upregulated the expression of (Cx43) as compared to I/R group. 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione gap junction protein, alpha 1 Rattus norvegicus
4 Therefore, our study demonstrated that TDZD-8 provided a protection to the kidney against I/R injury in rats through inducing the expression of (Cx43). 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione gap junction protein, alpha 1 Rattus norvegicus